StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Medpace Holdings, Inc.
NasdaqGS:MEDP
Sector
Industries
Location
Market Cap
USD 9.24 B
Share Price
USD 321.50
Avg Daily Volume
494,823
Change (1 day)
-1.39%
Change (1 year)
-20.24%
Change (YTD)
-3.23%
Medpace Holdings, Inc. Revenue Year-on-Year (YoY) growth for the Trailing 12 Months (TTM) ending March 31, 2025: 9.87%
Medpace Holdings, Inc. Revenue Year-on-Year (YoY) growth is 9.87% for the Trailing 12 Months (TTM) ending March 31, 2025. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period. Year-on-Year (YoY) growth is the change in a financial metric compared to the same period in the previous year, expressed as a percentage.
-
Medpace Holdings, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.96 B, a 25.57% change year over year.
-
Medpace Holdings, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.56 B, a 28.83% change year over year.
-
Medpace Holdings, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.21 B, a 27.05% change year over year.
-
Medpace Holdings, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 955.01 M, a 7.17% change year over year.
Competitors
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Medtronic plc
USD 88.39
MDT
+0.11
0.12%
RELX Plc
USD 53.17
REL.L
-0.07
-0.14%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
Key Data
| Date | Revenue Year-on-Year (YoY) growth | Gross Profit | Operating Income | EBIT |
|---|
Competitors
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Medtronic plc
USD 88.39
MDT
+0.11
0.12%
RELX Plc
USD 53.17
REL.L
-0.07
-0.14%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%